150 related articles for article (PubMed ID: 31437115)
1. Prognostic factors for survival in patients with completely resected pN2 non-small-cell lung cancer.
Sezen CB; Aksoy Y; Sonmezoglu Y; Citak N; Saydam O; Metin M
Acta Chir Belg; 2021 Feb; 121(1):23-29. PubMed ID: 31437115
[TBL] [Abstract][Full Text] [Related]
2. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival of patients with pN2 lung cancer according to the pattern of lymphatic spread.
Legras A; Mordant P; Arame A; Foucault C; Dujon A; Le Pimpec Barthes F; Riquet M
Ann Thorac Surg; 2014 Apr; 97(4):1156-62. PubMed ID: 24582052
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
6. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
[TBL] [Abstract][Full Text] [Related]
7. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
[TBL] [Abstract][Full Text] [Related]
9. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.
Yang CF; Kumar A; Gulack BC; Mulvihill MS; Hartwig MG; Wang X; D'Amico TA; Berry MF
J Thorac Cardiovasc Surg; 2016 May; 151(5):1380-8. PubMed ID: 26874598
[TBL] [Abstract][Full Text] [Related]
11. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
Bille A; Woo KM; Ahmad U; Rizk NP; Jones DR
Eur J Cardiothorac Surg; 2017 Apr; 51(4):674-679. PubMed ID: 28200091
[TBL] [Abstract][Full Text] [Related]
12. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
Fukui T; Mori S; Yokoi K; Mitsudomi T
J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
[TBL] [Abstract][Full Text] [Related]
13. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
Wang S; Zhou W; Zhang H; Zhao M; Chen X
Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
[TBL] [Abstract][Full Text] [Related]
14. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer.
Misthos P; Sepsas E; Athanassiadi K; Kakaris S; Skottis I
Eur J Cardiothorac Surg; 2004 Apr; 25(4):502-8. PubMed ID: 15037262
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
Liu K; Chen HL; You QS; Huang JF; Wang H
Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
[TBL] [Abstract][Full Text] [Related]
17. Oncological outcomes after lobe-specific mediastinal lymph node dissection via multiport video-assisted thoracoscopic surgery.
Mun M; Nakao M; Matsuura Y; Ichinose J; Okumura S
Eur J Cardiothorac Surg; 2020 Aug; 58(Suppl_1):i92-i99. PubMed ID: 32533183
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis and prognostic factor after extended lymphadenectomy in lung cancer].
Sakao Y; Hata E; Miyamoto H; Harada R; Hamada T
Nihon Kyobu Geka Gakkai Zasshi; 1997 May; 45(5):711-7. PubMed ID: 9170862
[TBL] [Abstract][Full Text] [Related]
19. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]